The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 21, 2014

Filed:

Apr. 02, 2012
Applicants:

David Hockenbery, Seattle, WA (US);

Julian Simon, Seattle, WA (US);

Inventors:

David Hockenbery, Seattle, WA (US);

Julian Simon, Seattle, WA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/47 (2006.01); C07D 217/22 (2006.01); C07D 401/12 (2006.01); C07C 251/86 (2006.01); C07D 271/08 (2006.01); C07D 213/77 (2006.01); C07C 323/20 (2006.01); C07C 235/60 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); C07C 251/86 (2013.01); C07D 271/08 (2013.01); C07D 213/77 (2013.01); C07C 323/20 (2013.01); C07C 235/60 (2013.01); C07D 217/22 (2013.01);
Abstract

Compounds are described that are useful for treating an apoptosis-associated disease, which are specifically cytotoxic to tumor cells that are overexpressing Bcl-x, and are much less cytotoxic in isogenic cells that are not overexpressing Bcl-x. Also described is a method for treating an apoptosis-associated disease in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of an active compound that is specifically cytotoxic to tumor cells that are overexpressing Bcl-x, and are much less cytotoxic in isogenic cells that are not overexpressing Bcl-x. Several scaffolds of active compounds are described.


Find Patent Forward Citations

Loading…